ATE388687T1 - Medikamentöse verabreichung von nikotin in form von kaugummi - Google Patents
Medikamentöse verabreichung von nikotin in form von kaugummiInfo
- Publication number
- ATE388687T1 ATE388687T1 AT99946722T AT99946722T ATE388687T1 AT E388687 T1 ATE388687 T1 AT E388687T1 AT 99946722 T AT99946722 T AT 99946722T AT 99946722 T AT99946722 T AT 99946722T AT E388687 T1 ATE388687 T1 AT E388687T1
- Authority
- AT
- Austria
- Prior art keywords
- minutes
- nicotine
- delivery system
- active
- chewing
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 5
- 229960002715 nicotine Drugs 0.000 title abstract 5
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 5
- 229940112822 chewing gum Drugs 0.000 title abstract 2
- 235000015218 chewing gum Nutrition 0.000 title abstract 2
- 235000019788 craving Nutrition 0.000 abstract 3
- 230000001055 chewing effect Effects 0.000 abstract 2
- 230000000144 pharmacologic effect Effects 0.000 abstract 2
- 239000007853 buffer solution Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Confectionery (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/146,696 US6358060B2 (en) | 1998-09-03 | 1998-09-03 | Two-stage transmucosal medicine delivery system for symptom relief |
| IE980991 | 1998-11-27 | ||
| US36089699A | 1999-07-26 | 1999-07-26 | |
| US09/389,339 US6344222B1 (en) | 1998-09-03 | 1999-09-02 | Medicated chewing gum delivery system for nicotine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE388687T1 true ATE388687T1 (de) | 2008-03-15 |
Family
ID=27452112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99946722T ATE388687T1 (de) | 1998-09-03 | 1999-09-03 | Medikamentöse verabreichung von nikotin in form von kaugummi |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1107730B1 (de) |
| AT (1) | ATE388687T1 (de) |
| AU (2) | AU776019B2 (de) |
| CA (1) | CA2346330C (de) |
| MX (1) | MXPA01002300A (de) |
| WO (1) | WO2000013662A2 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001037814A1 (en) * | 1999-11-23 | 2001-05-31 | Robert Gordon University | Bilayered buccal tablets comprising nicotine |
| SE0102197D0 (sv) * | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
| GB2376884A (en) * | 2001-06-26 | 2002-12-31 | Peter Hajek | Helping smokers stop |
| US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
| EA012306B1 (ru) * | 2003-01-24 | 2009-08-28 | Магле Холдинг Аб | Композиционный материал для доставки через слизистые оболочки |
| DK1817014T3 (da) | 2004-11-30 | 2012-11-19 | Fertin Pharma As | Fremgangsmåde til ydelse af hurtig afhjælpning til en bruger af et nikotintyggegummi |
| US8323683B2 (en) | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
| JP2010518845A (ja) * | 2007-02-26 | 2010-06-03 | リヴォリマー リミテッド | 薬用チューインガム |
| EP2361081B1 (de) * | 2008-10-14 | 2016-06-29 | McNeil AB | Aus mehreren portionen bestehende intraorale dosierform und ihre verwendung |
| DK2442668T3 (en) * | 2009-06-19 | 2016-12-12 | Fertin Pharma As | Buffered RUBBER BASE FOR HIGH PH RELEASE |
| US8623332B2 (en) | 2011-07-06 | 2014-01-07 | Fertin Pharma A/S | Chewing gum having sustained release of nicotine |
| AU2017322677B2 (en) | 2016-09-09 | 2020-12-17 | Takasago International Corporation | Taste modulating aldehydes |
| SE541358C2 (en) | 2017-05-30 | 2019-08-13 | Enorama Pharma Ab | Nicotine-containing chewing gum compositions |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| WO2021116842A1 (en) * | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with controlled release |
| US12310959B2 (en) | 2019-12-09 | 2025-05-27 | Nicoventures Trading Limited | Oral compositions with reduced water content |
| US12439949B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US12439952B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Moist oral compositions |
| US12433321B2 (en) | 2019-12-09 | 2025-10-07 | Nicoventures Trading Limited | Oral composition with beet material |
| CN112220756B (zh) * | 2020-10-16 | 2023-06-13 | 重庆市义力医药科技有限公司 | 一种尼古丁颗粒组合物及其制备方法 |
| USD1081739S1 (en) | 2021-04-06 | 2025-07-01 | Altria Client Services Llc | Die for gum forming |
| CA3223902A1 (en) | 2021-06-25 | 2022-12-29 | Richard Svensson | Oral products and method of manufacture |
| WO2025024287A1 (en) * | 2023-07-21 | 2025-01-30 | Altria Client Services Llc | Controlled-release nicotine chewing gum |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
| US3877468A (en) | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
| US3845217A (en) * | 1972-11-16 | 1974-10-29 | Helsingborg L Ab | Buffered smoking substitute compositions |
| US5824334A (en) | 1989-09-05 | 1998-10-20 | University Of Utah Research Foundation | Tobacco substitute |
| US5488962A (en) | 1990-10-10 | 1996-02-06 | Perfetti, S.P.A. | Chewing gum which is a substitute for tobacco smoke |
| EP0828489A4 (de) | 1996-03-13 | 2001-04-04 | Univ Yale | Raucherentwöhnungsbehandlung unter verwendung von naltrexon und verwandten verbindungen |
-
1999
- 1999-09-03 CA CA2346330A patent/CA2346330C/en not_active Expired - Fee Related
- 1999-09-03 MX MXPA01002300A patent/MXPA01002300A/es active IP Right Grant
- 1999-09-03 WO PCT/US1999/020105 patent/WO2000013662A2/en not_active Ceased
- 1999-09-03 AT AT99946722T patent/ATE388687T1/de not_active IP Right Cessation
- 1999-09-03 EP EP99946722A patent/EP1107730B1/de not_active Revoked
- 1999-09-03 AU AU59068/99A patent/AU776019B2/en not_active Ceased
-
2004
- 2004-11-19 AU AU2004231204A patent/AU2004231204B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004231204B2 (en) | 2007-11-29 |
| EP1107730A2 (de) | 2001-06-20 |
| CA2346330A1 (en) | 2000-03-16 |
| AU2004231204A1 (en) | 2004-12-23 |
| EP1107730B1 (de) | 2008-03-12 |
| MXPA01002300A (es) | 2003-03-10 |
| WO2000013662A8 (en) | 2000-07-27 |
| AU5906899A (en) | 2000-03-27 |
| WO2000013662A2 (en) | 2000-03-16 |
| WO2000013662A9 (en) | 2000-11-09 |
| WO2000013662A3 (en) | 2000-09-21 |
| CA2346330C (en) | 2011-10-04 |
| AU776019B2 (en) | 2004-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE388687T1 (de) | Medikamentöse verabreichung von nikotin in form von kaugummi | |
| ES2569949T3 (es) | Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina | |
| EP1242013A4 (de) | Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung | |
| SE0102276D0 (sv) | Device and method for the administration of a medicament | |
| RU94040387A (ru) | Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака | |
| ATE298562T1 (de) | Hydrogelpartikel formulierungen | |
| NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
| CO5261582A1 (es) | Composiciones de valdecoxib | |
| NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
| ATE202926T1 (de) | Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung | |
| GR1000380B (el) | Μορφη δοσολογιας εχουσα μειωμενη πιθανοτητα καταχρησης. | |
| ATE321529T1 (de) | Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung | |
| DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
| TR200103613T2 (tr) | Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. | |
| SE9601528D0 (sv) | Transdermally administered dextromethorphan as antitissue agent | |
| DK1052973T3 (da) | Transmucosale formuleringer af levosimendan | |
| PL348202A1 (en) | Pharmaceutically active composition and dispensing device | |
| EA200200914A1 (ru) | Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина | |
| MY124346A (en) | Medicated chewing gum delivery system for nicotine | |
| PT1144420E (pt) | Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao | |
| PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan | |
| SE9802555D0 (sv) | New pharmaceutical preparation and method | |
| CO5150206A1 (es) | Metodo para la prevencion o reduccion de episodios cardiovasculares asociados con intervenciones coronarias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |